Release data for formulation F12 (Span 60)
Formulation, characterization and drug release kinetics of floatingdrugdeliverysystems
12
FORMULATION AND EVALUATION OF NITROFURANTOIN SUSTAINED RELEASE CAPSULE
13
FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF ACEBROPHYLLINE
12
FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF VILDAGLIPTIN
7
Formulation and evaluation of almotriptan controlled release pellets
7
FORMULATION AND EVALUATION OF NATEGLINIDE SUSTAINED RELEASE TABLETS
6
A new time-independent formulation of fractional release
22
FORMULATION AND EVALUATION OF IRBESARTAN IMMEDIATE RELEASE TABLETS
6
FORMULATION AND EVALUATION OF MIGLITOL SUSTAINED RELEASE TABLETS
5
Formulation Development and Evaluation of Sustained Release Tablets of Aceclofenac
128
Ch. 12 Mitosis F12
37
Mucoadhesive Sustained Release Formulation of Lamivudine
6
FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF AMOXICILLINE
7
Formulation and Release Kinetic Study of Sustained Release Pellets of Diclofenac Sodium
11
Formulation and Evaluation of Capecitabine Immediate Release Tablets
118
Formulation and Evaluation of Indomethacin Extended Release Pellets.
111
Formulation and Evaluation of Extended Release Minitablets of Risperidone.
72
FORMULATION AND OPTIMIZATION OF SUSTAINED RELEASE TABLET OF PREGABALIN
10
FORMULATION AND EVALUATION OF VILDAGLIPTIN IMMEDIATE RELEASE TABLET
13
FORMULATION AND DEVELOPMENT OF SUSTAINED RELEASE PELLETS OF GLIPIZIDE
12